Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

RELMADA THERAPEUTICS, INC. (RLMD)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Jun-30-19Jun-30-18Jun-30-17Jun-30-16
   10-K10-K10-K10-K10-K10-K10-K10-K
Net income  -157.0-125.8-59.5-15.0-17.3-9.0-6.3-3.0
Depreciation and amortization   [+] 0.00.00.00.00.00.10.1
Stock-based compensation  44.240.520.83.21.20.50.71.2
Change in working capital   [+]10.6-7.910.80.11.70.5-0.60.7
Other operating activities  -1.51.20.0-0.43.92.0-0.3-12.1
Cash from operations  -103.8-91.9-27.8-12.1-10.5-6.0-6.5-13.1
   
Capital expenditures  0.00.00.0-84.80.00.00.0-0.6
Sales of short-term investments  67.0168.9      
Other cash from investing  -47.3-223.0-34.44.7    
Cash from investing  19.7-54.1-34.4-80.20.00.00.0-0.6
   
Issuance of common stock, net  0.0184.619.8     
Option exercises    0.7     
Other cash from financing  45.03.39.4126.117.56.5-0.3-0.3
Cash from financing  45.0187.928.5126.117.56.5-0.3-0.3
   
Free cash flow  -103.8-91.9-27.8-96.9-10.5-6.0-6.5-13.7
        Per share (diluted)  ($3.50)($5.23)($1.78)($10.49)($1.66)($0.48)($0.54)($1.18)
   
Cash paid for interest    0.00.00.00.00.00.0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy